Dan Ives, Wedbush global head of technology research, joins 'Closing Bell: Overtime' to discuss Salesforce after the ...
Wedbush analyst Seth Basham reiterated a Buy rating on Chewy (CHWY – Research Report) today and set a price target of $39.00. The company’s shares opened today at $32.78. Don't Miss our Black Friday ...
We recently compiled a list of the 12 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a ...
There’s a 2% chance bitcoin can become all of money, which would then value the cryptocurrency at $5 million, analyst says ...
Vivek Ramaswamy, the incoming co-chair of President-elect Donald Trump’s commission to cut government spending, has set his ...
Fintel reports that on December 3, 2024, Wedbush downgraded their outlook for Cavco Industries (NasdaqGS:CVCO) from ...
Wedbush analyst Daniel Ives says that in “another Twilight Zone” legal move from Chancellor McCormick of the Delaware Court of Chancery yet ...
Salesforce (CRM) is set to report fiscal third-quarter results tomorrow after the close of trading, and Wedbush Securities is ...
Investing.com -- Wedbush analysts expect tech stocks to end the year strongly with a “Santa rally,” citing positive catalysts ...
Wedbush upgraded Voyager Therapeutics (VYGR) to Outperform from Neutral with a price target of $11, up from $7, after ...
Additionally, one closely watched Wall Street analyst said that AI software stocks would be winners in 2025. As a result, ...
Wedbush has assumed coverage of Voyager Therapeutics (NASDAQ:VYGR) with an outperform rating, highlighting the company’s TRACER platform. The investment firm said it believes TRACER alone should ...